• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A. 2014 Nov 10. pii: 201408605. [Epub ahead of print]
Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity.
Wagner K1, Kwakkenbos MJ1, Claassen YB1, Maijoor K1, B?hne M1, van der Sluijs KF2, Witte MD3, van Zoelen DJ4, Cornelissen LA4, Beaumont T1, Bakker AQ1, Ploegh HL3, Spits H5.
Author information
Abstract

Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodies. Many different formats of bispecific antibodies have meanwhile been developed. Most are genetic modifications of the antibody backbone to facilitate incorporation of two different variable domains into a single molecule. Here, we present a bispecific format where we have fused two full-sized IgG antibodies via their C termini using sortase transpeptidation and click chemistry to create a covalently linked IgG antibody heterodimer. By linking two potent anti-influenza A antibodies together, we have generated a full antibody dimer with bispecific activity that retains the activity and stability of the two fusion partners.
KEYWORDS:

antibody engineering; immunotherapy; influenza

PMID:
25385586
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25385586
 
Back
Top Bottom